Advent Orlando - Florida Cardiology
Welcome,         Profile    Billing    Logout  
 2 Trials 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Siddiqui, Usman
NCT06223789: VOLT-AF IDE Clinical Study

Active, not recruiting
N/A
435
Europe, Canada, US, RoW
Pulsed Field Ablation
Abbott Medical Devices
Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
01/26
01/26
INTEGRA-D, NCT05855135: Assessment of Combined CCM and ICD Device in HFrEF

Recruiting
N/A
300
US
OPTIMIZER® Integra CCM-D System (Treatment Arm)
Impulse Dynamics
Heart Failure, Heart Failure with Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
06/25
12/25
NCT03643224: DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Completed
N/A
376
Europe, Canada, US, RoW
Radiofrequency Ablation
Medtronic Cardiac Rhythm and Heart Failure
Persistent Atrial Fibrillation, Atrial Fibrillation
10/24
10/24
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Recruiting
N/A
620
US
OPTIMIZER Smart System
Impulse Dynamics
Heart Failure
03/26
03/26
NCT05412927: AngelMed Guardian® System PMA Post Approval Study

Recruiting
N/A
500
US
PMA P150009 AngelMed Guardian® System
Angel Medical Systems
Acute Coronary Syndrome
12/26
12/26
NCT05997446: Amulet™ ADVANCE LAA

Active, not recruiting
N/A
610
US
Left atrial appendage occlusion (LAAO)
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
06/27
06/27
NCT04502316: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Recruiting
N/A
5000
US
Barostim™ System
CVRx, Inc.
Heart Failure
06/28
06/28
DAF PAS, NCT05230524: DIAMOND AF Post-Approval Study

Recruiting
N/A
225
Europe, US
DiamondTemp™ Ablation System
Medtronic Cardiac Rhythm and Heart Failure
Paroxysmal Atrial Fibrillation
01/29
01/29
Valesquez, Damaris
NCT04680026: A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

Active, not recruiting
2
150
Canada, US, RoW
HBI-3000, sulcardine sulfate, Placebo
HUYABIO International, LLC.
Atrial Fibrillation
12/24
12/24

Download Options